Desymmetrization-like catalytic enantioselective fluorination of malonates and its application to pharmaceutically attractive molecules

Angewandte Chemie - International Edition

Volumn 47, Issue 1, 2008, Pages 164-168

  Reddy, Dhande Sudhakar ^a   Shibata, Norio ^a   Nagai, Jun ^a   Nakamura, Shuichi ^a   Toru, Takeshi ^a   Kanemasa, Shuji ^b  

^a NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Asymmetric synthesis; Chiral Lewis acids; Desymmetrization; Enantioselectivity; Fluorination

Indexed keywords

CATALYST ACTIVITY; ENANTIOSELECTIVITY; FLUORINATION; MOLECULAR STRUCTURE; SYNTHESIS (CHEMICAL);

ASYMMETRIC SYNTHESIS; CHIRAL LEWIS ACIDS; DESYMMETRIZATION;

DRUG PRODUCTS;

FLUORINATED HYDROCARBON; MALONIC ACID DERIVATIVE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; STEREOISOMERISM; SYNTHESIS;

CATALYSIS; DRUG DESIGN; HYDROCARBONS, FLUORINATED; MALONATES; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 37549054653     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200704093     Document Type: Article

References (92)

1. a) P. Kirsch, Modern Fluoroorganic Chemistry, Wiley-VCH, Weinheim, 2004;
2. b) Enantiocontrolled Synthesis of Fluoroorganic Compounds (Ed.: V. A. Soloshonok), John Wiley and Sons, Chichester, 1999.
3. a) G. Haufe, J. Fluorine Chem. 2004, 125, 875-894;
4. b) G. Haufe, Sci. Synth. 2006, 34, 345-378;
5. c) G. Resnati, Tetrahedron 1993, 49, 9385-9445.
6. a) A. Yoshizawa, I. Nishiyama, T. Iría (Jpn. Kokai Tokkyo Koho), Jpn. 03112944, 1991;
7. b) K. Yoshino, M. Ozaki, K. Nakao, H. Taniguchi, N. Yamasaki, K. Satoh, Liq. Cryst. 1989, 5, 1203-1211;
8. c) H. Taniguchi, M. Ozaki, K. Yoshino, Jpn. J. Appl. Phys. 1987, 26, 101-103;
9. d) K. Yoshino, M. Ozaki, H. Taniguchi, M. Ito, Y. Kazuo, N. Yamasaki, T. Kitazume, Chem. Exp. 1987, 2, 56-63.
10. a) G. Haufe, A. Burchardt, Eur. J. Org. Chem. 2001, 4501-4507;
11. b) A. Burchardt, T. Takahashi, Y, Takeuchi, G. Haufe, J. Org. Chem. 2001, 66, 2078-2084;
12. c) Y. Ogawa, K. Iga, Y. Igari, Eur. Pat. Appl. 331504, 1989;
13. d) T. Okutani, K. Ukawa, H. Yamamoto, T. Amano, H. Nombra, K. Ootsu, Y. Kozai, Chem. Pharm. Bull. 1986, 34, 713-719;
14. e) O. Miyashita, T. Kasahara, Y. Wada, Chem. Pharm. Bull. 1982, 30, 3005-3009;
15. f) O. Miyashita, T. Kasahara, K. Mastumura, H. Shimadzu, M. Takamoto, N. Hashimoto, Chem. Pharm. Bull. 1982, 30, 2333-2341;
16. g) T. Marunaka, Y. Umeno, Chem. Pharm. Bull. 1982, 30, 1868-1871.
17. a) A. Abouabdellah, L. Boros, F. Gyenes, J. T. Welch, J. Fluorine Chem. 1995, 72, 255-259;
18. b) A. Abouabdellah, J. T. Welch, Tetrahedron: Asymmetry 1994, 5, 1005-1013;
19. c) F. Leeper, M. Rock, J. Fluorine Chem. 1991, 51, 381-396;
20. d) A. Barch, W. Shanahan, Eur. Pat. Appl. 393575, 1990;
21. e) T. Kitazume, T. Yamamoto, J. Fluorine Chem. 1987, 35, 467-476.
22. a) K. Lee, Y. Choi, J. Hong, R. Schinazi, C. Chu, Nucleosides Nucleotides 1999, 18, 537-540;
23. b) M. Ihara, K. Satoh, Y. Ishida, N. Taniguchi, Y. Tokunaga, M. Takemura, K. Fukumoto, Heterocycles 1996, 42, 437-443;
24. c) A. Flohr, G. Guido, E. A. Kitas, J. U. Peters, W. Wostl, US patent 2005054633, 2005.
25. For enzymatic approaches, see a) E. Narisano, R. Riva, Tetrahedron: Asymmetry 1999, 10, 1223-1242;
26. b) T. Kitazume, T. Kobayashi, Synthesis 1987, 187-188;
27. c) G. Guanti, E. Narisano, R. Riva, Tetrahedron: Asymmetry 1998, 9, 1859-1862;
28. d) T. Kitazume, T. Yamamoto, J. Fluorine Chem. 1986, 31, 357-361;
29. e) T. Kitazume, K. Murata, T. Ikeya, J. Fluorine Chem. 1986, 32, 233-238;
30. f) T. Kitazume, T. Sato, T. Kobayashi, J. Org. Chem. 1986, 51, 1003-1006;
31. g) T. Kitazume, T. Sato, N. Ishikawa, Chem. Lett. 1984, 1811-1814;
32. h) T. Yamazaki, T. Yamamoto, T. Kitazume, J. Org. Chem. 1989, 54, 83-91;
33. i) A. Sattler, G. Haufe, Tetrahedron: Asymmetry 1995, 6, 2841-2848;
34. j) T. Kitazume, K. Murata, T. Ikeya, J. Fluorine Chem. 1986, 31, 143-150.
35. For chemical approaches,see a) P. Coe, M. Lohr, C. Rochin, J. Chem. Soc. Perkin Trans. 1 1998, 2803-2812;
36. b) M. Ihara, Y. Tanaka, N. Takahashi, Y. Okunaga, K. Fukumoto, J. Chem. Soc. Perkin Trans. 1 1997, 3043-3052;
37. c) M. Ihara, T. Kawabuchi, Y. Tokunaga, K. Fukumoto, Tetrahedron: Asymmetry 1994, 5, 1041-1050;
38. d) M. Ihara, N. Taniguchi, T. Kai, K. Satoh, K. Fukumoto, J. Chem. Soc. Perkin Trans. 1 1992, 221-227;
39. e) M. Sato, N. Kitazawa, C. Kaneko, Heterocycles 1992, 33, 105-110;
40. f) C. Dugave, J. Dubois, S, Bory, M. Gaudry, A. Marquel, Bull. Soc. Chim. Fr. 1991, 381-386;
41. g) S. Bruns, G. Haufe, J. Fluorine Chem. 2000, 104, 247-254;
42. h) G. Haufe, S. Bruns, Adv. Synth. Catal. 2002, 344, 165-171.
43. a) N. Shibata, J. Kohno, K. Takai, T. Ishimaru, S. Nakamura, T. Toru, S. Kanemasa, Angew. Chem. 2005, 117, 4276-4279;
44. Angew. Chem. Int. Ed. 2005, 44, 4204-4207;
45. b) N. Shibata, T. Ishimaru, T. Nagai, J. Kohno, T. Toru, Synlett 2004, 1703-1706;
46. c) N. Shibata, T. Ishimaru, M. Nakamura, T. Toru, Synlett 2004, 2509-2512;
47. d) N. Shibata, E. Suzuki, Y. Takeuchi, J. Am. Chem. Soc. 2000, 122, 10728-10729;
48. e) N. Shibata, E. Suzuki, T. Asahi, M. Shiro, J. Am. Chem. Soc. 2001, 123, 7001-7009;
49. f) N. Shibata, T. Ishimaru, E. Suzuki, K. L. Kirk, J. Org. Chem. 2003, 68, 2494-2497;
50. g) N. Shibata, H. Yasui, S. Nakamura, T. Toru, Synlett 2007, 1153-1157.
51. T. Suzuki, T. Goto, Y. Hamashima, M. Sodeoka, J. Org. Chem. 2007, 72, 246-250.
52. a) N. Shibata, T. Ishimaru, S. Nakamura, T. Toru, J. Fluorine Chem. 2007, 128, 469-483;
53. b) Y. Hamashima, M. Sodeoka, Synlett 2006, 1467-1478;
54. c) H. Ibrahim, A. Togni, Chem. Commun. 2004, 1147-1155;
55. J.-A. Ma, D. Cahard, Chem. Rev. 2004, 104, 6119-6146;
56. d) M. Tredwell, V. Gouverneur, Org. Biomol. Chem. 2006, 4, 26-32.
57. a) L. Hintermann, A. Togni, Angew. Chem. 2000, 112, 4530-4533;
58. Angew. Chem. Int. Ed. 2000, 39, 4359-4362;
59. b) D. Cahard, C. Audouard, J.-C. Plaquevent, N. Roques, Org. Lett. 2000, 2, 3699-3701;
60. c) B. Greedy, J. M. Paris, T. Vidal, V. Gouverneur, Angew. Chem. 2003, 115, 3413-3416;
61. Angew. Chem. Int. Ed. 2003, 42, 3291-3294;
62. d) Y. Hamashima, K. Yagi, H. Takano, L. Tamás, M. Sodeoka, J. Am. Chem. Soc. 2002, 124, 14530-14531;
63. e) Y. Hamashima, T. Suzuki, H. Takano, Y. Shimura, M. Sodeoka, J. Am. Chem. Soc. 2005, 127, 10164-10165;
64. f) J.-A. Ma, D. Cahard, Tetrahedron: Asymmetry 2004, 15, 1007-1011;
65. g) J.-A. Ma, D. Cahard, J. Fluorine Chem. 2004, 125, 1357-1361;
66. h) L. Bernardi, K. A. Jørgensen, Chem. Commun. 2005, 1324;
67. i) D. Enders, M. R. M. Hüttl, Synlett 2005, 991-993;
68. j)M. Marigo, D. Fielenbach, A. Braunton, A. Kjærsgaard, K. A. Jørgensen, Angew. Chem. 2005, 117, 3769-3772;
69. Angew. Chem. Int. Ed. 2005, 44, 3703-3706;
70. k) D. D. Steiner, N. Mase, C. F. Barbas III, Angew. Chem. 2005, 117, 3772-3776;
71. Angew. Chem. Int. Ed. 2005, 44, 3706-3710;
72. l) T. D. Beeson, D. W. C. MacMillan, J. Am. Chem. Soc. 2005, 127, 8826-8828.
73. a) M. E. Swarbrick, F. Gosselin, W. D. Lubell, J. Org. Chem. 1999, 64, 1993-2002;
74. b) F. Gosselin, W. D. Lubell, J. Org. Chem. 1998, 63, 7463-7471;
75. c) S. Yamazaki, T. Inoue, T. Hamada, T. Takada, K. Yamamoto, J. Org. Chem. 1999, 64, 282-286;
76. d) T. A. Ayers, Tetrahedron Lett. 1999, 40, 5467-5470.
77. a) T. Sekiguchi, K. Sato, T. Ishihara, T. Konno, H. Yamanaka, Chem. Lett. 2004, 33, 666-667;
78. b) J. P. Genêt, J. O. Durand, S. Ronald, M. Savignac, F. Jung, Tetrahedron Lett. 1997, 38, 69-72;
79. c) J. W. Clader, D. A. Burnett, M. A. Caplen, M. S. Domalski, D. Sundeep, W. Vaccaro, R. Sher, M. E. Browne, E. Margaret, H. Zhao, J. Med. Chem. 1996, 39, 3684-3693;
80. d) J. T. Welch, K. Araki, R. Kewecki, J. A. Wichtowski, J. Org. Chem. 1993, 58, 2454-2462.
81. a) N. Iwasawa, H. Hung, T. Mukaiyama, Chem. Lett. 1985, 1045-1048;
82. b) H. Huang, N. Iwasawa, T. Mukaiyama, Chem. Lett. 1984, 1465-1466.
83. a) M. Sakamoto, K. Yamamoto, K. Isshiki, T. Ishikura, Y. Fukagawa, T. Yoshioka, J. Antibiot. 1990, 43, 1254-1270;
84. b) K. Okamura, S. Hirata, Y. Okumura, Y. Fukagawa, Y. Shimauchi, K. Kouno, T. Ishikura, J. Antibiot. 1978, 31, 480-482.
85. T. Ogihara, Y. Tachi, H. Uno, Cardiovasc. Drug Rev. 1992, 10, 88-100.
86. a) M. Chopra, H. Beswick, M. Claperton, H. J. Dargie, W. E. Smith, J. McMurray, J. Cardiovasc. Pharmacol. 1992, 19, 330-340;
87. b) P. J. Shultz, L. Raij, Br. J. Clin. Pharmacol. 1989, 28, 151-157;
88. c) K. Przyklenk, R. A. Kloner, Am. Heart J. 1991, 121, 1319-1330;
89. d) C. Ribuot, R. Cardinal, L. Gouin, P. Moreau, D. Godin, M. Vermeulen, J. Champlain, L. Rochette, R. Nadeau, Cardiovasc. Res. 1994, 28, 221-227.
90. For the synthesis of fluorinated captopril, see Ref [5e].
91. Although we synthesized (S,S)-20 from (S)-2a with L-Val, (R,R)-20 is the HIV protease inhibitor; the enantiomer can be prepared from (R)-2a with D-Val.
92. C. Han, J. P. Lee, E. Lobkovsky, J. A. Porco, Jr., J. Am. Chem. Soc. 2005, 127, 10039-10044.